Deferred Tax Assets, Valuation Allowance of Atara Biotherapeutics, Inc. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Atara Biotherapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • Atara Biotherapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $368,401,000, a 22% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Atara Biotherapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $368,401,000 -$106,581,000 -22% 31 Dec 2024 10-K 07 Mar 2025 2024 FY
Q4 2023 $474,982,000 +$52,489,000 +12% 31 Dec 2023 10-K 07 Mar 2025 2024 FY
Q4 2022 $422,493,000 +$46,422,000 +12% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q4 2021 $376,071,000 +$88,722,000 +31% 31 Dec 2021 10-K 08 Feb 2023 2022 FY
Q4 2020 $287,349,000 +$82,100,000 +40% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q4 2019 $205,249,000 +$78,096,000 +61% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q4 2018 $127,153,000 +$79,856,000 +169% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q4 2017 $47,297,000 -$8,590,000 -15% 31 Dec 2017 10-K 26 Feb 2019 2018 FY
Q4 2016 $55,887,000 +$18,862,000 +51% 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q4 2015 $37,025,000 +$23,311,000 +170% 31 Dec 2015 10-K 09 Mar 2017 2016 FY
Q4 2014 $13,714,000 +$9,236,000 +206% 31 Dec 2014 10-K 04 Mar 2016 2015 FY
Q4 2013 $4,478,000 31 Dec 2013 10-K 26 Feb 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.